This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

United States Oncology Drug Delivery Preferences And Opportunities In Cancer Drug Delivery

NEW YORK, March 27, 2013 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:

United States Oncology Drug Delivery Preferences and Opportunities in Cancer Drug Delivery 

http://www.reportlinker.com/p01042201/United-States-Oncology-Drug-Delivery-Preferences-and-Opportunities-in-Cancer-Drug-Delivery .html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Drug_Delivery_Technology

Research Objectives

•Understand trends, dynamics, and parameters specific to the delivery of drugs to cancer patients in key treatment settings such as home, office, or infusion center. •Identify physician prescribing trends relative to drug delivery considerations. •Understanding the role of reimbursement in physician's choice of drug delivery. •Identify physicians' perception of different drug delivery approaches, as well as key drivers for adoption/non-adoption, compliance, and choice of delivery devices. •Identify drug delivery trends within the oncology area. •Determine product attributes relative to delivery that are considered to be important by physicians and patients. •Identify prospective patient preferences and willingness to try new technologies as well as determine key drivers of adoption/non-adoption.

Industry Background

Drug delivery is an important area of drug development in the pharmaceutical and biotechnology industry. In oncology, developers are interested in understanding the opportunities and parameters for delivery of drugs in outpatient settings, particularly in the home. This is important for biotechnology products used in this area as companies seek to design new products and evaluate new opportunities for targeted therapies and other cancer treatments. Scope: Drug Delivery Categories

The eleven drug delivery categories evaluated in this research are:

•Intravenous injection

•Subcutaneous (SC) injection

•Intramuscular (IM) injection

•Intravenous infusion

•Implantable infusion pump

•External infusion pump

•Transdermal patch

•Topical gel or cream

•Implant

•Oral

•Rectal

Executive Summary

•Across all cancer types, oral is currently the dominant ( percent) mode of drug delivery. Meanwhile, the availability and prescription of effective implantable infusion pump as an oncology drug delivery mode has the potential for higher patient acceptance compared to external infusion pump. However, a significant proportion ( percent) of patients who are unwilling to use external infusion pumps will still comply if the method is prescribed by a doctor.

•While cancer patients are least familiar with topical gel or cream for oncology treatment, percent of respondents reported that they would be willing to use this method for future oncology treatments, implying a potential for high growth rate.

1 of 3

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
SYM TRADE IT LAST %CHG

Markets

DOW 17,826.30 -279.47 -1.54%
S&P 500 2,081.18 -23.81 -1.13%
NASDAQ 4,931.8150 -75.9760 -1.52%

Partners Compare Online Brokers

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs